Overview

This trial is active, not recruiting.

Condition neoplasms
Phase phase 0
Sponsor University of Utah
Start date May 2012
End date December 2016
Trial size 34 participants
Trial identifier NCT01618344, SCH-13929

Summary

To explore use of a smartphone medication reminder application to promote adherence to oral medications by AYA with cancer.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Time perspective prospective

Primary Outcomes

Measure
Feasibility and acceptability of using a smartphone medication reminder application to promote adherence to oral medications by AYA with cancer.
time frame: ongoing study weeks 5-12

Eligibility Criteria

Male or female participants from 15 years up to 29 years old.

Inclusion criteria: 1)15-29 year olds receiving treatment for any type of cancer, either primary or recurrent/relapsed disease. 2) Patient has completed at least one month of therapy 3)Patient is expected to remain on therapy for 3 month duration of study 4) Patient has an iPhone, iPad, or iTouch running iOS 4.0 or later 5) Patient is willing to use a smartphone medication reminder application- Exclusion Criteria: 1)Patients who are unable to speak/read/write English as required for use of smartphone medication reminder application and completion of study measures.

Additional Information

Official title Use of a Smartphone Medication Reminder Application to Promote Adherence to Oral Medications by Adolescents and Young Adults(AYA) With Cancer
Principal investigator Yelena Wu, MD
Description Non-adherence to oral medications is a prevalent problem in adolescents and young adults (AYA) with cancer that may impact both survival and quality of life while on treatment. The purpose of this study is to explore use of a smartphone medication reminder application to promote adherence to oral medications by AYA with cancer. The study's primary aim is to explore the feasibility and acceptability of using a smartphone medication reminder application to promote adherence to oral medications by AYA with cancer as well as to characterize application use. Secondary aims include: 1) to obtain initial estimates of intervention effect- measured by pre-intervention to post-intervention differences in perceived behavioral control for adherence, intention to adhere, and adherence behavior - to inform design of a future trial powered to detect a clinically significant effect of smartphone medication reminder application use on adherence to oral medications; and 2) to examine the relationships among perceived behavioral control for adherence, intention to adhere, and adherence behavior. A pre-post single group design will be used. Data will be collected weekly for 4 weeks before introduction of the intervention and for 8 weeks following introduction of the intervention. Analytic approaches will include descriptive statistics and GEE modeling.
Trial information was received from ClinicalTrials.gov and was last updated in August 2016.
Information provided to ClinicalTrials.gov by University of Utah.
Location data was received from the National Cancer Institute and was last updated in August 2016.